Auxly Cannabis Group Inc. (XLY:CA) Q4 2025 Earnings Call Transcript

Auxly held its year-end 2025 earnings call, stating the company is now profitable, generating cash and investing for growth after a multi-year stabilization period; management resumed calls after almost three years. No specific revenue, profit or guidance figures were disclosed on the call; the message is a stabilization-to-growth narrative that could modestly influence the stock (likely single-digit percentage moves) as investors reassess fundamentals.

Analysis

Auxly's renewed engagement with investors and operating momentum creates a clear path for a multiple re-rating, but the actual rerate will be governed more by margin stability and retail shelf penetration than by headline profitability. If Auxly can convert incremental sales into consolidated SG&A leverage, a 25–50% uplift in EV/EBITDA is achievable within 6–12 months; conversely, a single quarter of shrinking retail sell-through or promotional mix shift could wipe out that uplift quickly.

Second-order winners include third-party packaging and white-label manufacturers who supply scalable SKUs — they benefit from one growing counterparty consolidating SKUs and order cadence, which raises their revenue visibility and creditworthiness over 12–24 months. Competitors exposed to high fixed-cost cultivation models and weaker provincial listing relationships (smaller LPs, certain MSO peers) are most at risk of margin compression as buyers reallocate shelf space to partners that demonstrate reliable fulfillment and SKU economics.

Key tail risks are regulatory/tax changes in provincial frameworks and a re-acceleration of heavy promotional pricing from dominant retailers; both can reverse momentum within a single quarter and are binary around government budget cycles or provincial procurement windows. Near-term catalysts to watch are retail listing updates, published gross margin trends, and inventory days-supply at provincial distributors — each can move valuation 15–30% on realization or disappointment over 3–9 months.

Key Decisions for Investors

• Long XLY.TO (size 3–5% NAV), dollar-cost over 4–6 weeks into any >5% pullbacks. Target +50% in 9–12 months if margin progression continues; place stop-loss at -25% or hedge with 6–12 month puts to cap downside. Rationale: asymmetric rerate if SKU execution and shelf gains continue, limited downside if hedged.
• Pair trade: Long XLY.TO / Short WEED.TO (equal notional, size 2–3% NAV). Timeframe 6–12 months. Reward: capture operational gearing and re-rating in Auxly vs valuation multiple re-compression risk in larger, structurally challenged peers; risk: sector-wide rerating would hurt both legs, require active monitoring of provincial inventory prints.
• Options collar for capital-efficient upside: Buy 12-month ATM XLY.TO call and sell 12-month 1.5x call (call spread) sized to 2% NAV exposure. Cost-limited trade with ~2:1 upside on premium if re-rating occurs; protects capital vs outright long while retaining meaningful upside.
• Tail hedge: Buy 9–12 month XLY.TO 25–30% OTM puts (small position, 0.5–1% NAV) to protect against regulatory/excise shock or a retail promo wave that destroys near-term margins. This keeps upside exposure while limiting catastrophic drawdown risk on binary policy events.